roxithromycin
Small moleculeexperimental
Roxithromycin is a semi-synthetic macrolide antibiotic used to treat respiratory tract, urinary and soft tissue infections. It is a derivative of erythromycin - comprising the same 14-membered lactone ring - with an oxime-based side chain attached to the macrolide ring. — Wikipedia
Clinical trial activity
7 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
3
Earliest trial started Nov 1, 1993 (NCT00621387)
Timeline
Indications
Approved for
Mechanism of action
- 50S ribosomal protein L2INHIBITOR
rplB inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O- Mol. weight
- 837.06 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRoxithromycin ↗
- ChEMBLCHEMBL1214185 ↗
Also known as
- (9e)-erythromycin 9-(o-((2-methoxyethoxy)methyl)oxime)
- (9e)-erythromycin 9-(o-((2-methoxyethoxy)methyl)oxime)
- claramid
- rotramin
- roxacin
- roxeptin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin
- roxithromycin a
- roxithromycine
- roxithromycine
- roxithromycinum
- roxithromycinum
- roxitromicina
- roxitromicina
- ru-28965
- ru-28965
- ru-965
- ru-965
- rulid
- rulid
- rulide
- rulide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06798051 | Phase 1 | Jun 3, 2019 | Guizhou Medical University |
| NCT03148444 | Phase 4 | Jun 1, 2017 | Hebrew University |
| NCT02819570 | Phase 4 | Nov 1, 2015 | Bar Ilan University, Western Galilee Hospital |
| NCT04122040 | Phase 3 | Mar 1, 2011 | Prince of Songkla University |
| NCT00439062 | Phase 4 | Jun 1, 2006 | Nazilli State Hospital |
| NCT00197379 | N/A | May 1, 2005 | Hamamatsu University |
| NCT00621387 | N/A | Nov 1, 1993 | University of Helsinki |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bar Ilan University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Guizhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Hamamatsu University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Nazilli State Hospital | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Prince of Songkla University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Helsinki | Academic/Hospital | 1 | 1 | 1 | 1993 |
| Western Galilee Hospital | Academic/Hospital | 1 | 1 | 1 | 2015 |
8 organizations
Page 1 / 1